Beacon Pointe Advisors LLC boosted its stake in shares of The Clorox Company (NYSE:CLX – Get Rating) by 27.9% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 6,703 shares of the company’s stock after buying an additional 1,463 shares during the period. Beacon Pointe Advisors LLC’s holdings in Clorox were worth $945,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Wetherby Asset Management Inc. grew its stake in shares of Clorox by 84.3% in the 1st quarter. Wetherby Asset Management Inc. now owns 9,506 shares of the company’s stock worth $1,321,000 after buying an additional 4,347 shares in the last quarter. M&T Bank Corp lifted its holdings in shares of Clorox by 10.7% in the 2nd quarter. M&T Bank Corp now owns 31,464 shares of the company’s stock worth $4,060,000 after acquiring an additional 3,052 shares during the last quarter. Yousif Capital Management LLC lifted its holdings in shares of Clorox by 5.7% in the 2nd quarter. Yousif Capital Management LLC now owns 56,622 shares of the company’s stock worth $7,983,000 after acquiring an additional 3,055 shares during the last quarter. Verity Asset Management Inc. bought a new stake in shares of Clorox in the 1st quarter worth about $192,000. Finally, Swiss National Bank lifted its holdings in Clorox by 14.0% during the 1st quarter. Swiss National Bank now owns 532,183 shares of the company’s stock valued at $73,989,000 after buying an additional 65,400 shares in the last quarter. 81.69% of the stock is owned by hedge funds and other institutional investors.
Clorox Stock Performance
Shares of Clorox stock opened at $149.11 on Friday. The firm has a market capitalization of $18.40 billion, a P/E ratio of 45.74, a P/E/G ratio of 3.15 and a beta of 0.31. The Clorox Company has a 52 week low of $120.50 and a 52 week high of $186.86. The company has a quick ratio of 0.50, a current ratio of 0.88 and a debt-to-equity ratio of 4.99. The firm’s 50 day moving average is $138.80 and its two-hundred day moving average is $141.67.
Clorox Announces Dividend
Analysts Set New Price Targets
A number of brokerages recently weighed in on CLX. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Clorox from $138.00 to $148.00 and gave the company a “hold” rating in a report on Wednesday, November 2nd. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $129.00 to $126.00 and set an “underweight” rating for the company in a report on Thursday, October 13th. UBS Group boosted their price target on shares of Clorox from $119.00 to $129.00 and gave the company a “sell” rating in a report on Wednesday, November 2nd. StockNews.com started coverage on shares of Clorox in a report on Wednesday, October 12th. They issued a “hold” rating for the company. Finally, Barclays lifted their price objective on shares of Clorox from $93.00 to $101.00 and gave the stock an “underweight” rating in a research report on Friday, August 19th. Ten research analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $135.08.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- Microsoft Shares: Is it Time to Back Up the Truck?
- Three CBD Stocks to Dominate a Budding Industry
- Is the 60/40 Portfolio Mix Still in Vogue?
- Institutional Support for Analog Devices Remains High
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.